Featured Research

from universities, journals, and other organizations

AIDS Vaccine Program At St. Jude Children's Research Hospital Gets First Step FDA Approval

Date:
October 18, 1997
Source:
St. Jude Children's Research Hospital
Summary:
In the first step of a multi-tier AIDS vaccine development program at St. Jude Children's Research Hospital, the Food and Drug Administration (FDA) has approved a Phase I safety trial of a new AIDS vaccine designed to trigger immune responses to multiple, differing isolates of HIV using the harmless outer coating of HIV known as the envelope.

MEMPHIS, Tenn., October 17, 1997-- In the first step of a multi-tier AIDS vaccinedevelopment program at St. Jude Children's Research Hospital, the Food and DrugAdministration (FDA) has approved a Phase I safety trial of a new AIDS vaccinedesigned to trigger immune responses to multiple, differing isolates of HIVusing the harmless outer coating of HIV known as the envelope.

Envelope vaccines have been shown in other laboratories to protect safelyprimates challenged with an immunodeficiency virus sharing the same HIVenvelope, as illustrated in August by research reported in the Proceedings ofthe National Academy of Sciences by scientists at Harvard Medical School. TheSt. Jude multi-envelope AIDS vaccine strategy is unique in combining 23different envelopes that represent many different isolates of HIV.

"Our ultimate aim is to discover the number and mix of HIV proteins, gatheredfrom HIV isolates found throughout the world, which will be effective inpreventing infection regardless of the isolate to which people are exposed,"says Julia Hurwitz, Ph.D., a co-developer of the St. Jude multi-envelope AIDSvaccine with Karen Slobod, M.D., respectively of the Departments of Immunologyand Infectious Diseases at St. Jude Children's Research Hospital.

The Phase I safety trial approved in September by the FDA will get underwayimmediately, beginning with the recruitment and evaluation of 9-18 eligible,healthy human volunteers, and is expected to last one to two years.

"At St. Jude Hospital we are very proud of the progress Drs. Slobod, Hurwitz andtheir colleagues have made in bringing the St. Jude multi-envelope AIDS vaccineto its first trial and they have our strongest possible support as they andtheir colleagues continue to pursue an AIDS vaccine," said Arthur W. Nienhuis,M.D., Director of St. Jude Children's Research Hospital.

Although every viral envelope consists of proteins called gp120 and gp41, eachenvelope looks different to the immune system because the proteins vary, muchlike human faces differ from each other. These differences have been an obstacleto vaccine development.

Scientists at St. Jude Children's Research Hospital have built upon theknowledge obtained by other vaccine research groups to select the buildingblocks -- or backbones -- for their HIV vaccine. One backbone is the smallpoxvaccine that globally eradicated smallpox in humans by the late 1970s. St. JudeChildren's Research Hospital is using 23 different HIV envelopes each containedin a smallpox vaccine backbone to constitute the first component of the St. Judemulti-envelope AIDS vaccine.

The St. Jude research team is also developing vaccine boosters as part of thevaccine program. Boosters include a DNA vaccine in which injected DNA promptsthe production by the body's cells of envelope proteins that then stimulate theimmune system. The DNA vaccine strategy was co-developed by Robert Webster,Ph.D., chair of the Department of Virology and Molecular Biology at St. JudeChildren's Research Hospital. Drs. Slobod and Hurwitz may also deliver abooster of purified envelope proteins.

The incorporation of many envelopes in the St. Jude multi-envelope AIDS vaccinestrategy is aimed at representing a cross section of virus envelopes that haveemerged in developing and developed regions of the world during the 15-yearglobal epidemic. Collecting the HIV envelopes, isolating the envelope sequencesand other related research efforts were initiated at St. Jude Children'sResearch Hospital four years ago.

"Although complete implementation of this vaccine strategy will take years, weare moving as quickly as possible without sacrificing attention to safety,quality and the St. Jude commitment to excellence," says Dr. Slobod.

While testing the safety of the St. Jude multi-envelope AIDS vaccine during theupcoming Phase I trial, the St. Jude research team will also measure volunteers'immune system response to the vaccine by evaluating their B cell (antibody) andT cell (cellular) immune responses. These data may be a preliminary indicationof volunteers' expected immune response to the vaccine during later trials. TheSt. Jude team constructed the vaccine in a manner that will permit determinationof whether immune system responses are the result of vaccination or actual HIVinfection unrelated to the vaccination.

Since the late 1980s, St. Jude Children's Research Hospital has also been activein developing treatments for children with AIDS. It is part of the AIDSClinical Trial Group, a national cooperative research network which allowspediatric AIDS researchers across the country to share resources andinformation.

St. Jude Children's Research Hospital, in Memphis, Tenn., was founded by thelate entertainer Danny Thomas. The hospital is an internationally recognizedbiomedical research center dedicated to finding cures for catastrophic diseasesof childhood. The hospital's work is primarily supported through funds raisedby the American Lebanese Syrian Associated Charities (ALSAC). All St. Judepatients are treated regardless of their ability to pay. ALSAC covers all costsof treatment beyond those reimbursed by third party insurers, and total costsfor families who have no insurance.


Story Source:

The above story is based on materials provided by St. Jude Children's Research Hospital. Note: Materials may be edited for content and length.


Cite This Page:

St. Jude Children's Research Hospital. "AIDS Vaccine Program At St. Jude Children's Research Hospital Gets First Step FDA Approval." ScienceDaily. ScienceDaily, 18 October 1997. <www.sciencedaily.com/releases/1997/10/971018005342.htm>.
St. Jude Children's Research Hospital. (1997, October 18). AIDS Vaccine Program At St. Jude Children's Research Hospital Gets First Step FDA Approval. ScienceDaily. Retrieved September 20, 2014 from www.sciencedaily.com/releases/1997/10/971018005342.htm
St. Jude Children's Research Hospital. "AIDS Vaccine Program At St. Jude Children's Research Hospital Gets First Step FDA Approval." ScienceDaily. www.sciencedaily.com/releases/1997/10/971018005342.htm (accessed September 20, 2014).

Share This



More Health & Medicine News

Saturday, September 20, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Could Grief Affect The Immune Systems Of Senior Citizens?

Could Grief Affect The Immune Systems Of Senior Citizens?

Newsy (Sep. 19, 2014) The study found elderly people are much more likely to become susceptible to infection than younger adults going though a similar situation. Video provided by Newsy
Powered by NewsLook.com
Jury Delivers Verdict in Salmonella Trial

Jury Delivers Verdict in Salmonella Trial

AP (Sep. 19, 2014) A federal jury has convicted three people in connection with an outbreak of salmonella poisoning five years ago that sickened hundreds of people and was linked to a number of deaths. (Sept. 19) Video provided by AP
Powered by NewsLook.com
How The 'Angelina Jolie Effect' Increased Cancer Screenings

How The 'Angelina Jolie Effect' Increased Cancer Screenings

Newsy (Sep. 19, 2014) Angelina's Jolie's decision to undergo a preventative mastectomy in 2013 inspired many women to seek early screenings for the disease. Video provided by Newsy
Powered by NewsLook.com
The Cost of Ebola

The Cost of Ebola

Reuters - Business Video Online (Sep. 18, 2014) As Sierra Leone prepares for a three-day "lockdown" in its latest bid to stem the spread of Ebola, Ciara Lee looks at the financial implications of fighting the largest ever outbreak of the disease. Video provided by Reuters
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins